# Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

> **NCT00246922** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 150 (—)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT00246922
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-01
- **Primary completion:** 2007-01-01
- **Final completion:** 2007-10-01
- **Target enrollment:** 150 (—)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246922, "Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00246922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*